BKDNYSEServices-Nursing & Personal Care FacilitiesFiscal year ends December 31
Brookdale Senior Living Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$9.86−0.23 (-2.28%)
Close on Oct 19, 2026
- Market cap
- $2.40B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
26.2%+3.7 pts over 5 years
Operating margin
0.4%+3.2 pts over 5 years
Net margin
-8.2%−10.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +2.2% | +4.2% | -2.0% | -4.3% | |
| Gross profit | +4.8% | +12.1% | +1.0% | -5.3% | |
| Operating income | -71.0% | – | – | – | |
| Free cash flow | – | – | -3.6% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -17.8% | 11.0% | -313.2% | |
| Return on assets | -4.2% | 1.2% | -4.3% | |
| Current ratio | 0.85 | 1.12 | 0.98 | |
| Debt to equity | 1.71 | 4.89 | -95.92 | |
| Net debt to EBITDA | 6.58× | 12.89× | 10.46× | |
| Interest coverage | -0.1× | -0.5× | – | |
| Capex to revenue | 6.7% | 5.3% | 6.3% | |
| Diluted shares | 186M | 184M | 235M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Brookdale Senior Living generated $645.05M from operations and spent $1.01B on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$645.05M
Used
$1.01B
Capital expenditure$1.01B100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-8.2%
×Asset turnover0.52×
×Equity multiplier73.26×
=Return on equity, FY2025-313.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -8.2% | 0.52× | 73.26× | -313.2% |
| FY2024 | -6.5% | 0.52× | 19.33× | -65.5% |
| FY2023 | -6.3% | 0.52× | 11.67× | -38.3% |
| FY2022 | -8.4% | 0.46× | 9.65× | -37.3% |
| FY2021 | -3.6% | 0.41× | 8.89× | -13.3% |
| FY2020 | 2.3% | 0.50× | 9.42× | 11.0% |
| FY2019 | -6.6% | 0.59× | 7.96× | -31.2% |
| FY2018 | -11.7% | 0.64× | 5.55× | -41.4% |
| FY2017 | -12.0% | 0.56× | 4.68× | -31.7% |
| FY2016 | -8.1% | 0.52× | 4.25× | -17.8% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$262.69M
- Cash generatingOperating cash flow above zero$218.03M
- Return on assets improvedROA up on the prior year-3.6% → -4.1%
- Earnings backed by cashOperating cash flow above net income$218.03M vs -$262.69M
- Less leverageLong-term debt to assets fell63.5% → 70.8%
- Better liquidityCurrent ratio rose0.88 → 0.98
- No dilutionShare count did not rise228M → 235M
- Gross margin improvedGross margin up on the prior year25.57% → 26.22%
- More efficientAsset turnover rose0.56 → 0.50